This article has been disseminated on behalf of Diagnos Inc. and may include paid advertising.
Diagnos (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) provided an update on the regulatory pathway for its CARA artificial intelligence platform for early detection of eye-related health issues, following its previously announced acceleration plan. The Corporation confirmed progress across three targeted jurisdictions, including formal submission to the Saudi Food and Drug Authority for marketing approval, ongoing engagement with Health Canada with a formal application expected this quarter, and clarification of 510(k) requirements with the U.S. Food & Drug Administration, positioning CARA for potential commercialization in key global markets.
To view the full press release, visit https://ibn.fm/uUewJ
About DIAGNOS
DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale.
Additional information is available at www.diagnos.com and www.sedarplus.com.
NOTE TO INVESTORS: The latest news and updates relating to DGNOF are available in the company’s newsroom at https://ibn.fm/DGNOF
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Austin, Texas
www.InvestorWire.com
512.354.7000 Office
[email protected]
InvestorWire is powered by IBN